Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The binding site for C1q on IgG.

A R Duncan1, G Winter

  • 1MRC Laboratory of Molecular Biology, Cambridge, UK.

Nature
|April 21, 1988
PubMed
Summary
This summary is machine-generated.

Antibodies initiate pathogen clearance by binding antigens and activating complement. Researchers identified specific amino acids (Glu 318, Lys 320, Lys 322) in the antibody Fc region crucial for C1q binding and complement activation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a sprayable hydrogel formulation for the skin application of therapeutic antibodies.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2019
Same author

Structure determination and crystal chemistry of large repeat mixed-layer hexaferrites.

IUCrJ·2018
Same author

Letter to the Editor.

Radiography (London, England : 1995)·2017
Same author

Preliminary evaluation of cytosine-phosphate-guanine oligodeoxynucleotides bound to gelatine nanoparticles as immunotherapy for canine atopic dermatitis.

The Veterinary record·2017
Same author

Testing and clinical implications for non-V600 BRAF mutations in metastatic NRAS<sup>mt</sup> melanoma.

The British journal of dermatology·2016
Same author

Clinical Research Abstracts of the British Equine Veterinary Association Congress 2015.

Equine veterinary journal·2015
Same journal

Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

Nature·2026
Same journal

China boosts prestigious grants for young scientists - will it ease competition?

Nature·2026
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
See all related articles

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Antibodies are key in humoral immunity, mediating pathogen clearance through mechanisms like complement lysis.
  • The complement cascade initiates with C1q binding to the antibody Fc region, a process sensitive to ionic strength and conserved across species.
  • Initial C1q binding to isolated antibody Fc regions is weak, but multivalent binding significantly enhances affinity.

Purpose of the Study:

  • To precisely map the C1q binding site on the antibody Fc region.
  • To identify specific amino acid residues involved in the C1q-antibody interaction.
  • To investigate the functional significance of the identified binding site in complement activation.

Main Methods:

  • Systematic mutagenesis of surface residues in the mouse IgG2b isotype.

Related Experiment Videos

  • Analysis of C1q binding affinities to altered antibody variants.
  • Testing the efficacy of a peptide mimic of the identified binding site in inhibiting complement lysis.
  • Main Results:

    • Localized the C1q binding site to three specific side chains: Glu 318, Lys 320, and Lys 322 in the mouse IgG2b Fc region.
    • These residues are conserved in other antibody isotypes.
    • A peptide mimicking this sequence motif effectively inhibited complement lysis.

    Conclusions:

    • The identified sequence motif (Glu 318, Lys 320, Lys 322) represents a critical binding site for C1q on IgG antibodies.
    • This conserved motif is essential for initiating the classical complement pathway.
    • The findings provide a molecular basis for C1q-antibody interactions and potential therapeutic targeting.